Humanitarian Factor IX donation to Afghanistan
Kedrion Biopharma confirms its commitment to broaden access to therapies in developing Countries
Multimedia project for hemophilia patients in Italy
WebApp Weemo launched by FedEmo with the support of Kedrion Biopharma
SIPPET Study was WHF 2016 World Congress highlight
A Kedrion, Grifols and LFB supported symposium featured a lecture by Dr. Manuel Carcao
Kedrion Biopharma consolidates presence on Russian market
Joint venture with Nacimbio of RosTECH group for a technology transfer to Kirov plant
Kedrion Biopharma awarded “Best Carpooling Company” 2015
775 kg of CO2 saved in the last year alone. Employees: “This is a great opportunity!”
Kedrion Biopharma cycles with FIDAS at the 99th Giro d’Italia
The objective is to promote blood and plasma donations and dispel misconceptions
SIPPET study results published in the “New England Journal of Medicine”
This investigator-initiated clinical study involved 42 hemophilia treatment centers from all over the world
Italian TV broadcasted report on CURhE, global initiative supported by Kedrion Biopharma
RAI’s medical special featured Italian neonatologist Giuseppe Buonocore, one of the founders of the Consortium
Kedrion Biopharma for Mother’s Day
We are committed to helping eliminate Rh disease worldwide by supporting initiatives like CURhE
Kedrion initiatives for World Hemophilia Day 2016
The goal is to improve access to treatments for people suffering from hemorrhagic conditions